Skip to main content
BSX
NYSE Industrial Applications And Services

Boston Scientific Makes $1.5B Strategic Investment in MiRus for TAVR Technology, Option for $3B Acquisition

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$53.3
Mkt Cap
$78.301B
52W Low
$52.52
52W High
$109.5
52W Position info
1.5% above low
Off High info
51% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

BSX is trading near its 52-week low of $52.52 (1.5% above the low).

Summary

Boston Scientific has made a $1.5 billion strategic investment in MiRus LLC for a 33.75% equity stake, securing an exclusive option to acquire MiRus's TAVR business for an additional $3.0 billion upon achieving clinical and regulatory milestones.


Key Events · M&A and Partnerships · BSX

  • Strategic Investment in MiRus LLC

    Boston Scientific acquired a 33.75% equity interest in MiRus LLC for a cash payment of $1.5 billion, in addition to a prior $100 million payment.

  • Exclusive Option for TAVR Business Acquisition

    The company secured an exclusive option to acquire MiRus's TAVR-Structural Heart NewCo, which holds the Siegel TAVR System assets, for an additional $3.0 billion upon achievement of clinical and regulatory milestones.

  • Focus on Novel TAVR System

    The investment targets the Siegel TAVR system, an investigational device currently undergoing the STAR pivotal clinical trial, which features a nickel-free rhenium alloy design and smaller delivery sheath.

  • Immaterial Near-Term Financial Impact

    The investment is expected to be immaterial to Boston Scientific's adjusted earnings per share for 2026, signaling a long-term strategic play.


Analysis · BSX · Industrial Applications And Services

This filing details a significant strategic move by Boston Scientific to expand its presence in the transcatheter aortic valve replacement (TAVR) market. The initial $1.5 billion cash investment, with a potential additional $3.0 billion for full acquisition, represents a substantial capital commitment for an investigational device. While the TAVR system is still in clinical trials and carries regulatory risk, its differentiated technology could offer a long-term growth driver for the company. The investment is not expected to impact 2026 adjusted earnings per share, indicating a focus on future market position rather than immediate financial returns.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, BSX was trading at $53.30 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $78.3B. The 52-week trading range was $52.52 to $109.50. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BSX - Latest Insights

BSX
Nov 02, 2026, 5:54 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $44.16
Real-time Price: $43.52 info
Change: -$0.645 (-1%) info
Market Cap: $63.241B info
BSX
Nov 02, 2026, 5:26 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $44.24
Real-time Price: $43.52 info
Change: -$0.725 (-2%) info
Market Cap: $63.241B info
BSX
Oct 29, 2026, 3:00 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $42.15
Real-time Price: $43.52 info
Change: +$1.36 (+3%) info
Market Cap: $63.241B info
BSX
Oct 28, 2026, 10:52 AM EDT
Source: Benzinga
Importance Score:
8
Price at Filing: $42.11
Real-time Price: $43.52 info
Change: +$1.41 (+3%) info
Market Cap: $63.241B info
BSX
Oct 28, 2026, 6:34 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $42.85
Real-time Price: $43.52 info
Change: +$0.665 (+2%) info
Market Cap: $63.241B info